摘要
目的观察小儿支气管哮喘急性发作采用布地奈德混悬液联合吸入用异丙托溴铵治疗的临床疗效。方法将2016年1月—2017年12月接诊的84例支气管哮喘急性发作患儿作为研究对象,将其随机分为参照组和研究组,每组各42例。参照组采用布地奈德混悬液治疗,研究组在此基础上,联合吸入用异丙托溴铵治疗。比较两组患儿临床症状消失时间以及治疗效果。结果研究组患儿咳嗽消失时间、呼吸困难消失时间、肺部哮鸣音消失时间以及住院时间均短于参照组;治疗总有效率为95.24%,高于参照组的76.19%,差异均具有统计学意义(P<0.05)。结论对小儿支气管哮喘急性发作采用布地奈德混悬液联合吸入用异丙托溴铵治疗疗效确切,有利于加速患儿临床症状消失,提高其整体治疗效果。
Objective To observe the clinical efficacy of budesonide suspension combined with ipratropium bromide aerosol treatment of children with acute exacerbation of bronchial asthma.Methods84children with acute attack of bronchial asthma from January2016to December2017were studied.They were randomly divided into the reference group and the research group,42cases in each group.The control group was treated with budesonide suspension.On this basis,the study group was treated with ipratropium bromide combined with inhalation.The disappearance time of clinical symptoms and the therapeutic effect were compared between the two groups.Results The cough disappearance time,dyspnea disappearance time,pulmonary wheezing disappearance time and hospitalization time in the study group were shorter than those in the control group.The total effective rate was95.24%,which was higher than76.19%of the control group(P<0.05).Conclusion The combination of budesonide suspension and ipratropium bromide inhalation is effective in the treatment of acute attack of bronchial asthma in children,which is conducive to speeding up the disappearance of clinical symptoms and improving the overall therapeutic effect.
作者
张璐洁
唐燕
忻悦
ZHANG Lujie;TANG Yan;XIN Yue(Department of Pediatrics, Zhenjiang Ruikang Hospital, Zhenjiang Jiangsu 212000,China;Department of Pediatrics, The Affiliated Hospital of Jiangsu University, Zhenjiang Jiangsu 212000, China)
出处
《中国继续医学教育》
2018年第35期121-123,共3页
China Continuing Medical Education
关键词
小儿支气管哮喘
急性发作
布地奈德
异丙托溴铵
联合吸入
临床疗效
children with bronchialasthma
acuteexacerbation
budesonide
ipratropium
combined inhalation
clinical effect
